Indeed, a lack of MGMT gene promoter methylation, which leads to an elevated expression of functional MGMT proteins, has been observed in approximately half of GBM tumors and is linked to TMZ resistance in GBM [1,2,5,6,7,13]. This evidence concerns the gene MGMT and glioblastoma.